tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co Ltd (JP:4536)
:4536
Japanese Market

Santen Pharmaceutical Co (4536) Income Statement

Compare
0 Followers

Santen Pharmaceutical Co Income Statement

Last quarter (Q2 2026), Santen Pharmaceutical Co's total revenue was ¥69.14B, a decrease of -3.48% from the same quarter last year. In Q2, Santen Pharmaceutical Co's net income was ¥8.06B. See Santen Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 300.00B¥ 301.96B¥ 279.04B¥ 266.26B¥ 249.60B
Gross Profit
¥ 171.03B¥ 178.71B¥ 166.09B¥ 156.59B¥ 151.38B
Operating Expenses
¥ 120.88B¥ 126.42B¥ 134.07B¥ 120.70B¥ 113.59B
Depreciation and Amortization
¥ 17.95B¥ 18.18B¥ 17.25B¥ 17.05B¥ 17.92B
EBITDA
¥ 68.83B¥ 56.46B¥ 14.30B¥ 54.52B¥ 30.01B
Operating Income
¥ 56.23B¥ 51.90B¥ 32.02B¥ 35.89B¥ 37.07B
Other Income/Expenses
¥ -8.75B¥ -22.03B¥ -37.81B¥ -270.00M¥ -25.38B
Pretax Income
¥ 47.48B¥ 29.87B¥ -5.80B¥ 35.62B¥ 11.69B
Net Income
¥ 36.25B¥ 26.64B¥ -14.95B¥ 27.22B¥ 9.31B
Per Share Metrics
Basic EPS
¥ 103.98¥ 72.62¥ -38.60¥ 68.07¥ 23.30
Diluted EPS
¥ 103.68¥ 72.37¥ -38.60¥ 67.97¥ 23.26
Weighted Average Shares Outstanding
348.61M 366.89M 387.42M 399.77M 399.46M
Weighted Average Shares Outstanding (Diluted)
349.69M 368.14M 387.42M 400.46M 400.39M
Currency in JPY

Santen Pharmaceutical Co Earnings and Revenue History